Bactiguard enters development partnership in the dental field
STOCKHOLM, April 8, 2022 /PRNewswire/ -- Bactiguard today entered an agreement to initiate a global development partnership with Dentsply Sirona in the dental field, a new application area for the Bactiguard technology. The initial development phase, which is expected to last approximately one y...
Correction: Year-end report 2021 Bactiguard Holding AB
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- In previous press releases regarding the year-end report for 2021, incorrect information related to "Cash flow from operating activities" has been reported. Correction is made with this press release and the correct PDF is attached for Bactiguard Holding AB...
Bactiguard presents focused growth strategy and sets new long-term financial targets
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard presents new long-term financial targets in connection with the year-end report for 2021. The new financial targets relate to growth and profitability, with annual revenues of at least1 billion SEK and annual EBITDA of at least 400 million SEK in...
Bactiguard and Zimmer Biomet expand global license partnership
STOCKHOLM, Feb. 9, 2022 /PRNewswire/ -- Bactiguard and Zimmer Biomet have today agreed to expand the global license partnership, that was initiated in 2019, to cover multiple product segments. The extended exclusive license agreement covers implants for joint reconstruction (hips and knees), spo...
Interim report for Q3 2021 : Bactiguard Holding AB (publ)
STOCKHOLM, Oct. 28, 2021 /PRNewswire/ -- Capital injection initiates a new phase of accelerated expansion Third quarter (July-September 2021) * Revenues amounted to SEK 45.2 (34.1) million, an increase of 32%. Adjusted for currency effects revenues increased by 36%. * EBITDA amounted to SEK ...
New clinical trial shows 53% reduction of ventilator-associated pneumonia with Bactiguard's endotracheal tube
STOCKHOLM, Oct. 5, 2021 /PRNewswire/ -- This week at the European Society of Intensive Care congress (ESICM), a study from Liège,Belgium on Bactiguard's endotracheal tubes was presented. The study showed a 53% reduction in ventilator-associated pneumonia (VAP) in intensive care patients, intubate...
Bactiguard completes a directed new share issue to AMF, raising approximately SEK 228 million
The board of directors of Bactiguard Holding AB (publ) ("Bactiguard") has resolved on a directed new share issue of1,500,000 B shares at a price of SEK 152 per share, corresponding to approximately SEK 228 million. STOCKHOLM, Sept. 22, 2021 /PRNewswire/ -- The Board of Directors of Bactiguard ha...
Bactiguard appoints new CEO
The Board of Bactiguard Holding AB (publ) has today appointed Anders Göransson as the new CEO. Anders has extensive experience from consulting within McKinsey and has held several senior positions in Amgen, most recently as Head of Innovation Europe. Anders will start his employment in Bactiguard...
A large randomized clinical trial shows significant reduction in urinary tract infections
STOCKHOLM, March 12, 2021 /PRNewswire/ -- A recently published, randomized, controlled multicenter study inIndia shows that urinary catheters with Bactiguard's coating for infection prevention reduce the risk of catheter-associated urinary tract infections (CAUTI) by 69% compared to standard cat...
Health Canada provides COVID-19 Interim Order approval for Bactiguard's TempSensor catheter
STOCKHOLM , Feb. 9, 2021 /PRNewswire/ -- Health Canada has approved Bactiguard's urinary catheter with temperature sensor for infection prevention through an Interim Order. The approval is driven by COVID-19, as Bactiguard's catheters can reduce the risk of secondary infections for critically ill...
Bactiguard-coated Zimmer Biomet trauma implants receive European regulatory clearance
STOCKHOLM, Jan. 22, 2021 /PRNewswire/ -- Today, Bactiguard-coated Zimmer Biomet orthopaedic trauma implants received European regulatory clearance and CE mark. Preparations for registering the implants in the U.S. market are also ongoing. "I am very pleased that the CE mark has been secured for B...
Bactiguard: New order from China
STOCKHOLM, Dec. 30, 2020 /PRNewswire/ -- Bactiguard has received an initial order for coating concentrate from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate license revenues in the fourth quarter 2020 of approximately SEK 9 million. In parallel with th...
Bactiguard Donates Infection Prevention to China
STOCKHOLM, March 4, 2020 /PRNewswire/ -- In the fight against the Corona virus, Bactiguard donates products for infection prevention to Chinese hospitals, at a market value of over2 million SEK. "To help fight the new corona virus (covid-19) and protect the most severely ill patients, we will do...
Bactiguard Completes Acquisition of Vigilenz
STOCKHOLM, March 2, 2020 /PRNewswire/ -- Bactiguard Holding AB (publ) ("Bactiguard") has completed the acquisition of Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz), which was announced on4 February 2020. All conditions precedent have been fulfilled and the first part...
Bactiguard Makes its First Acquisition by Acquiring Vigilenz
STOCKHOLM, Feb. 4, 2020 /PRNewswire/ -- Bactiguard deepens the partnership that was initiated in 2015 by acquiring Vigilenz Medical Devices and Vigilenz Medical Supplies (together Vigilenz) in Malaysia. The acquisition strengthens Bactiguard's position in infection control and wound management, a...
New Major Order From China
STOCKHOLM, Dec. 27, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the fourth quarter of approximatelySEK 16.5 million. "This is the second order from Well Lead outside the initial...
Bactiguard Holding AB (publ): Interim Report for Q3 2019
STOCKHOLM, Nov. 7, 2019 /PRNewswire/ -- The new license agreement with Zimmer Biomet contributed to that we delivered the strongest quarter to date for Bactiguard as a listed company. The partnership with one of the three largest orthopedic companies in the world confirms the strength of Bactigua...
New Major Order From China
STOCKHOLM, Sept. 30, 2019 /PRNewswire/ -- Bactiguard has received a new order from Well Lead Medical (Well Lead) inChina. The order will be delivered promptly and generate revenues in the third quarter of approximatelySEK 4,8 million. "The order we have just received from Well Lead is the first ...
Bactiguard Signs Global License Agreement With Zimmer Biomet
STOCKHOLM, Sept. 27, 2019 /PRNewswire/ -- Bactiguard has entered into an exclusive, global license agreement for orthopedic trauma implants with Zimmer Biomet. The agreement includes an upfront license fee ofUSD 3 million payable at signing, additional contingent payments ofUSD 2 million, based o...
Bactiguard Recruits Experienced Chief Medical and Technology Officer
STOCKHOLM, Sept. 5, 2019 /PRNewswire/ -- Stefan Grass with extensive clinical experience as a physician and researcher, combined with senior positions in the pharmaceutical industry, has been recruited to a newly established, global role as Chief Medical and Technology Officer. He will assume his...
